Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Central Airway Stenosis

NANot yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

November 1, 2027

Study Completion Date

November 1, 2030

Conditions
Adult Subjects With Symptomatic Benign Airway ObstructionAdult Benign Central Airway StenosisAdult Tracheobronchial StenosisTracheal StenosisCentral Airway StenosisCentral Airway Obstruction
Interventions
COMBINATION_PRODUCT

The Airiver Pulmonary drug-coated balloon (DCB) dilation

drug coated balloon dilation

DEVICE

Commercial airway balloon dilation

uncoated airway balloon dilation

Sponsors
All Listed Sponsors
lead

Airiver Medical, Inc.

INDUSTRY

NCT07191860 - Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Central Airway Stenosis | Biotech Hunter | Biotech Hunter